Axsome Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2016 to Q4 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Axsome Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2016 to Q4 2024.
  • Axsome Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending February 11, 2025 was 48.8M shares, a 2.94% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 48.8M +1.39M +2.94% Feb 11, 2025 10-K 2025-02-18
Q3 2024 48.5M +1.14M +2.42% Nov 5, 2024 10-Q 2024-11-12
Q2 2024 48M +809K +1.72% Jul 29, 2024 10-Q 2024-08-05
Q1 2024 47.5M +3.92M +9% Apr 29, 2024 10-Q 2024-05-06
Q4 2023 47.4M Feb 13, 2024 10-K 2024-02-23
Q3 2023 47.3M +3.89M +8.97% Oct 31, 2023 10-Q 2023-11-06
Q2 2023 47.2M +6.89M +17.1% Jul 31, 2023 10-Q 2023-08-07
Q1 2023 43.6M +4.66M +12% May 1, 2023 10-Q 2023-05-09
Q3 2022 43.4M +5.73M +15.2% Oct 31, 2022 10-Q 2022-11-07
Q2 2022 40.3M +2.62M +6.96% Aug 1, 2022 10-Q 2022-08-09
Q1 2022 38.9M +1.34M +3.58% Apr 26, 2022 10-Q 2022-05-02
Q3 2021 37.7M +348K +0.93% Nov 1, 2021 10-Q 2021-11-08
Q2 2021 37.7M +398K +1.07% Aug 2, 2021 10-Q 2021-08-09
Q1 2021 37.6M +495K +1.34% May 3, 2021 10-Q 2021-05-10
Q3 2020 37.3M +2.84M +8.22% Oct 30, 2020 10-Q/A 2020-11-06
Q2 2020 37.3M +2.87M +8.33% Aug 3, 2020 10-Q 2020-08-10
Q1 2020 37.1M +3.8M +11.4% Mar 6, 2020 10-K 2020-03-12
Q3 2019 34.5M +4.7M +15.8% Nov 1, 2019 10-Q 2019-11-07
Q2 2019 34.4M +8.17M +31.1% Aug 2, 2019 10-Q 2019-08-08
Q1 2019 33.3M +7.79M +30.5% Mar 11, 2019 10-K 2019-03-15
Q3 2018 29.8M +6.14M +25.9% Nov 2, 2018 10-Q 2018-11-09
Q2 2018 26.3M +2.64M +11.2% Aug 3, 2018 10-Q 2018-08-08
Q1 2018 25.5M +6.3M +32.8% Mar 2, 2018 10-K 2018-03-07
Q3 2017 23.7M +4.52M +23.6% Nov 3, 2017 10-Q 2017-11-08
Q2 2017 23.6M +4.46M +23.3% Aug 4, 2017 10-Q 2017-08-09
Q1 2017 19.2M +46.9K +0.25% Mar 2, 2017 10-K 2017-03-07
Q3 2016 19.2M Nov 9, 2016 10-Q 2016-11-14
Q2 2016 19.1M Aug 3, 2016 10-Q 2016-08-09
Q1 2016 19.1M May 3, 2016 10-Q/A 2016-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.